Sharlene Day is a Cardiology physician. OpenAlex indexes 262 publications with 12,884 citations (h-index 57); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Blvd
2 West
Philadelphia, PA 191045127
Telephone
215-615-4949Registry record last updated 15 Jul 2019.
Clinical trials
- Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lexicon Pharmaceuticals, Inc.Program year20253 payments
- Lexicon Pharmaceuticals, Inc.Program year20245 payments$13,601openpaymentsdata.cms.gov ↗
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.8%Beta blocker24.2%Metoprolol Succinate100%Part D<11 patientsAldosterone antagonist (MRA)21.1%Spironolactone100%Part D<11 patients+ 2 more classes in this area
Blood & clotting
24.2%Factor Xa inhibitor24.2%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Risk Alleles in Protein Quality Control Genes as Modifiers of Hypertrophic Cardiomyopathy
University of Pennsylvania
FY2026$694,990R01HL168841 - SGLT-inhibitors in patients with hypertrophic cardiomyopathy
University of Pennsylvania
FY2026$671,727R33HL164376 - Missense Variants in Myosin Binding Protein C that Cause Hypertrophic Cardiomyopathy
University of Pennsylvania
FY2026$669,508R01HL167524
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities
Journal of the American College of Cardiology
2025 - 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”